Worldwide Webb Acquisition (NASDAQ:WWAC – Get Free Report) and Moolec Science (NASDAQ:MLEC – Get Free Report) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.
Analyst Recommendations
This is a summary of current ratings and target prices for Worldwide Webb Acquisition and Moolec Science, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Worldwide Webb Acquisition | 0 | 0 | 0 | 0 | 0.00 |
Moolec Science | 0 | 0 | 1 | 0 | 3.00 |
Moolec Science has a consensus target price of $6.00, suggesting a potential upside of 647.20%. Given Moolec Science’s stronger consensus rating and higher probable upside, analysts clearly believe Moolec Science is more favorable than Worldwide Webb Acquisition.
Risk and Volatility
Insider & Institutional Ownership
49.1% of Worldwide Webb Acquisition shares are owned by institutional investors. Comparatively, 0.1% of Moolec Science shares are owned by institutional investors. 43.0% of Worldwide Webb Acquisition shares are owned by insiders. Comparatively, 19.9% of Moolec Science shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Worldwide Webb Acquisition and Moolec Science’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Worldwide Webb Acquisition | N/A | N/A | N/A |
Moolec Science | -129.97% | -97.95% | -27.91% |
Valuation & Earnings
This table compares Worldwide Webb Acquisition and Moolec Science”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Worldwide Webb Acquisition | N/A | N/A | N/A | N/A | N/A |
Moolec Science | $5.62 million | 5.49 | -$7.31 million | ($0.20) | -4.02 |
Worldwide Webb Acquisition has higher earnings, but lower revenue than Moolec Science.
Summary
Worldwide Webb Acquisition beats Moolec Science on 6 of the 10 factors compared between the two stocks.
About Worldwide Webb Acquisition
Worldwide Webb Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of direct-to-consumer brands, amazon-centric, online marketplace, food tech, new media, digital health, software-as-a-service, fintech, and others. The company was incorporated in 2021 and is based in Orem, Utah.
About Moolec Science
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Receive News & Ratings for Worldwide Webb Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Worldwide Webb Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.